Indian Market Summary – 25 February 2026

Major Indices

Index	Close (25 Feb 2026)	Change
Nifty 50	25,482.50	+0.23 %
BSE Sensex	82,276.07	+0.06 %
Nifty Next 50	70,399.25	+0.89 %
Bank Nifty	61,043.35	–0.01 %
Fin Nifty	28,339.65	+0.16 %

Key Statistics:

• Rupee: appreciated 6 paise to ₹90.89 per US$; a firmer currency limited imported inflation.
• India VIX: fell 4.66 % to 13.49, signalling a decline in short‑term volatility.
• FII/DII flows (24 Feb): Foreign institutional investors were net sellers (≈₹102 crore), while domestic institutions bought roughly ₹3,161 crore, helping stabilise prices.
• Gift Nifty futures: indicated a firm start, trading about 62 points higher pre‑opening.

Sectoral Performance

Sector Index	Close	Change	Notes
Nifty IT	30,526.35	+1.57 %	Recovery in U.S. tech stocks and Anthropic’s partnership‑oriented AI strategy eased concerns of AI disruption in IT services.
Nifty Auto	28,466.50	+1.85 %	Lifted by expectations of sustained demand into FY27 after GST reforms; ICRA & Axis Securities see Q4 strength.
Nifty Pharma	23,051.85	+1.85 %	Driven by stock‑specific catalysts (Lupin’s USFDA approval, Aurobindo’s subsidiary).
Nifty Healthcare	14,898.35	+1.59 %	Positive momentum from pharma names.
Nifty Metal	notional (~52,369)	≈+2.7 %	Gains in Tata Steel, JSW Steel and Jindal Steel due to price‑target upgrades.
Nifty FMCG	52,105.30	–0.25 %	Mild profit‑taking after a recent rally.
Nifty Oil & Gas	12,188.90	–0.18 %	Profit‑booking and lower crude prices weighed.

Top Gainers & Losers (broader market)

Top gainers	LTP	Prev. close	% change
Sammaan Capital	157.94	153.42	+2.95 %
NALCO	359.80	343.00	+4.90 %
Vedanta	727.80	695.10	+4.70 %
Laurus Labs	1,076.35	1,028.50	+4.65 %
Aurobindo Pharma	1,211.50	1,164.40	+4.04 %

Top losers	LTP	Prev. close	% change
Waaree Energies	2,708.50	3,023.50	–10.42 %
Premier Energies	729.40	777.05	–6.13 %
IRFC	104.56	109.44	–4.46 %
Hindustan Petroleum	436.70	447.05	–2.32 %
Suzlon Energy	43.18	44.13	–2.15 %

52‑week high names:

NTPC, Adani Ports & SEZ, JSW Steel, Bajaj Auto and Tata Steel continued trading near their annual peaks.

52‑week lows:

IRFC touched a new low following the government’s Offer‑for‑Sale; Urban Company, Abbott, Hexaware and AWL Agri remained at the bottom end of their yearly ranges.

What Moved the Market

• IT rebound: Global technology stocks rebounded after Anthropic signalled partnerships around its Claude AI platform rather than outright disruption, which lifted Indian IT majors.
• Metals & auto strength: Upgrades on Tata Steel and JSW Steel and robust auto demand projections supported the metal and auto packs.
• Health‑care boost: Regulatory approvals (Lupin’s US FDA nod for Brivaracetam Oral Solution) and corporate developments (Aurobindo Pharma’s Engenra Biologics subsidiary) boosted pharma and healthcare stocks.
• Profit‑taking in FMCG & energy: Recent winners saw mild profit booking.
• Solar manufacturing slump: Waaree Renewable Technologies, Waaree Energies, Premier Energies and Vikram Solar tumbled 6–14 % as the U.S. announced a preliminary 126 % countervailing duty on Indian solar imports.
• Rupee appreciation & lower volatility: A stronger rupee and a fall in the VIX suggested stability, encouraging selective buying.
• Institutional flows: Continued domestic inflows cushioned markets against FII selling.

Global Cues

• US markets: Dow Jones gained 0.76 %, S&P 500 +0.77 %, while the Nasdaq slipped 1.05 %.
• Asia: Japan’s Nikkei rose ~1.4 %, Hang Seng +0.58 %, but China’s CSI 300 was up only 0.4 %.
• Commodities: Brent crude edged higher (~$71/bbl), gold and silver firmed up; this supported metal stocks.
• Other macro: Eurozone CPI and US durable‑goods orders were awaited; investors gauged whether strong global data would influence central‑bank expectations.

Stocks to Watch for 26 Feb 2026

• Power Grid Corp. – Cabinet approved raising its equity investment limit per subsidiary to ₹7,500 crore (from ₹5,000 crore), supporting expansion plans.
• Hindalco Industries / Novelis – Subsidiary Novelis plans to issue ~1.33 million common shares to AV Minerals for $150 each (~$200 million), signalling continued capex.
• Lupin – US FDA approved its Brivaracetam Oral Solution (10 mg/mL) for seizures; watch for follow‑through buying.
• Dr Reddy’s Laboratories – The US SEC closed an investigation into alleged improper payments without recommending action.
• IRFC – Government launched a 2 % stake sale with a green‑shoe option; stock fell to a fresh 52‑week low.
• Waaree Energies – Wholly owned subsidiary won a 300 MW wind project from SECI; however, shares slumped due to US duties on solar imports.

Corporate Updates

• Tata group optimism: Shares of Tata Motors passenger vehicles, Tata Elxsi and TCS rose roughly 3 % as the re‑appointment of Tata Sons’ chairman N Chandrasekaran was deferred, signalling continuity.
• Aurobindo Pharma – Incorporated Engenra Biologics to expand contract‑manufacturing capabilities; stock gained around 4 %.
• SpiceJet – Shares hit a 10 % lower circuit after an 8.4 % equity block deal (~15 crore shares), signalling supply overhang.
• Lupin – USFDA approval for Brivaracetam Oral Solution may strengthen its neurology portfolio.
• Government stake sales: IRFC saw selling pressure as the government offloaded up to 4 % stake via an Offer‑for‑Sale.
• Solar duties: U.S. imposition of a preliminary 126 % duty on Indian solar imports hammered solar‑manufacturing stocks, implying near‑term earnings pressure.

Technical Outlook & Market Tone for 26 Feb 2026

• Nifty 50: Technical charts indicate support near 25,400 and 25,100 and resistance at 25,600 and 25,900. Options positioning shows heavy put writing at 25,400 and call writing at 25,600. Short positions may be held with a stop‑loss near 25,824. A decisive move above 25,600 could open the door towards 25,900, while a break below 25,400 could drag the index towards 25,100.
• Bank Nifty: Support lies at 60,700 and 60,000, with resistance at 61,000 and 61,600. Bank Nifty remains in a positive trend; long positions may be trailed with a stop‑loss around 60,626. A move above 61,000 could lead to 61,600, whereas a fall below 60,700 may invite declines toward 60,000.
• Expected Tone: After Wednesday’s modest rebound, markets are likely to consolidate in a range‑bound fashion amid monthly derivatives settlement and global event risk. Positive global cues and easing fears around AI‑induced disruption are supportive, but investors will monitor further U.S. economic data and geopolitical developments. Expect stock‑specific action in sectors linked to metals, pharma, autos and power, with caution in solar and PSU banking names.

Bottom line:

The market’s recovery on 25 February owed much to an IT rebound, strength in metals and autos, and constructive domestic flows. While volatility has subsided, traders should watch the 25,400–25,600 band on Nifty for directional cues.